| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.49 | 2e-36 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-15 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-14 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-10 |